An autophagy-inhibitory metal-organic framework (MOF) nanoreactor was developed for tumor-targeted synergistic therapy. The nanoreactor could inhibit autophagy to enhance the glucose oxidase (GOx)-mediated starvation therapy. The H2O2 generated in this process induced the polarization of macrophages to the M1 phenotype, which further enhanced the therapeutic effect.